Alnylam Pharmaceuticals Total Non Current Liabilities 2011-2026 | ALNY

Annual Total Non Current Liabilities Alnylam Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	604 M	93.3 M	84 M	211 M	59.7 M	48 M	96.3 M	105 M	82.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
604 M	48 M	154 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Cabaletta Bio CABA	43.9 M	$ 3.37	3.45 %	$ 339 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.2	4.75 %	$ 5.27 M	Israel
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.73	3.04 %	$ 8.97 B	Australia
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	15 M	$ 7.36	-15.79 %	$ 72.8 M	USA
Esperion Therapeutics ESPR	355 M	$ 2.08	1.22 %	$ 432 M	USA
Evogene Ltd. EVGN	5.36 M	$ 0.86	4.76 %	$ 27.9 M	Israel
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Forte Biosciences FBRX	10.5 M	$ 31.11	-4.04 %	$ 403 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Galapagos NV GLPG	2.41 B	$ 29.11	0.8 %	$ 2.69 B	Belgium
Genmab A/S GMAB	769 M	$ 29.26	0.67 %	$ 18.8 B	Danmark
GT Biopharma GTBP	714 K	$ 0.38	-1.83 %	$ 2.1 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.69	1.45 %	$ 1.01 B	USA
Harmony Biosciences Holdings HRMY	149 M	$ 29.22	-0.24 %	$ 1.68 B	USA
BioNTech SE BNTX	341 M	$ 99.83	1.44 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
ImmuCell Corporation ICCC	11.5 M	$ 7.64	-1.18 %	$ 69 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
InflaRx N.V. IFRX	254 K	$ 1.21	6.14 %	$ 152 M	Germany
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	168 M	$ 1.54	-1.23 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.19	1.07 %	$ 448 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 24.26	-3.31 %	$ 3.09 B	USA
Incyte Corporation INCY	315 M	$ 97.7	0.01 %	$ 19.1 B	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	105 M	$ 1.66	1.57 %	$ 235 M	France
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.48	-0.34 %	$ 394 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands